Warf MB - Search Results

1

Analytical validation of a proliferation-based molecular signature used as a prognostic marker in early stage lung adenocarcinoma.

Warf MB, Fosso PG, Hughes E, Perry M, Brown KL, Reid JE, Kolquist KA, Wagner S, Gutin A, Roa B. Warf MB, et al. Biomark Med. 2015;9(9):901-10. doi: 10.2217/bmm.15.46. Epub 2015 Jul 9. Biomark Med. 2015. PMID: 26158298

2

Analytical validation of a melanoma diagnostic gene signature using formalin-fixed paraffin-embedded melanocytic lesions.

Warf MB, Flake DD 2nd, Adams D, Gutin A, Kolquist KA, Wenstrup RJ, Roa BB. Warf MB, et al. Biomark Med. 2015;9(5):407-16. doi: 10.2217/bmm.15.11. Epub 2015 Mar 27. Biomark Med. 2015. PMID: 25815401

3

An independent validation of a gene expression signature to differentiate malignant melanoma from benign melanocytic nevi.

Clarke LE, Flake DD 2nd, Busam K, Cockerell C, Helm K, McNiff J, Reed J, Tschen J, Kim J, Barnhill R, Elenitsas R, Prieto VG, Nelson J, Kimbrell H, Kolquist KA, Brown KL, Warf MB, Roa BB, Wenstrup RJ. Clarke LE, et al. Among authors: warf mb. Cancer. 2017 Feb 15;123(4):617-628. doi: 10.1002/cncr.30385. Epub 2016 Oct 21. Cancer. 2017. PMID: 27768230 Free PMC article.

4

Analytical validation of a 12-gene molecular test for the prediction of distant recurrence in breast cancer.

Warf MB, Rajamani S, Krappmann K, Doedt J, Cassiano J, Brown K, Reid JE, Kronenwett R, Roa BB. Warf MB, et al. Future Sci OA. 2017 Jun 5;3(3):FSO221. doi: 10.4155/fsoa-2017-0051. eCollection 2017 Aug. Future Sci OA. 2017. PMID: 28884016 Free PMC article.

5

Clinical validation of a gene expression signature that differentiates benign nevi from malignant melanoma.

Clarke LE, Warf MB, Flake DD 2nd, Hartman AR, Tahan S, Shea CR, Gerami P, Messina J, Florell SR, Wenstrup RJ, Rushton K, Roundy KM, Rock C, Roa B, Kolquist KA, Gutin A, Billings S, Leachman S. Clarke LE, et al. Among authors: warf mb. J Cutan Pathol. 2015 Apr;42(4):244-52. doi: 10.1111/cup.12475. Epub 2015 Apr 13. J Cutan Pathol. 2015. PMID: 25727210 Free PMC article.

6

Diagnostic Distinction of Malignant Melanoma and Benign Nevi by a Gene Expression Signature and Correlation to Clinical Outcomes.

Ko JS, Matharoo-Ball B, Billings SD, Thomson BJ, Tang JY, Sarin KY, Cai E, Kim J, Rock C, Kimbrell HZ, Flake DD 2nd, Warf MB, Nelson J, Davis T, Miller C, Rushton K, Hartman AR, Wenstrup RJ, Clarke LE. Ko JS, et al. Among authors: warf mb. Cancer Epidemiol Biomarkers Prev. 2017 Jul;26(7):1107-1113. doi: 10.1158/1055-9965.EPI-16-0958. Epub 2017 Apr 4. Cancer Epidemiol Biomarkers Prev. 2017. PMID: 28377414

7

Effects of ADARs on small RNA processing pathways in C. elegans.

Warf MB, Shepherd BA, Johnson WE, Bass BL. Warf MB, et al. Genome Res. 2012 Aug;22(8):1488-98. doi: 10.1101/gr.134841.111. Epub 2012 Jun 6. Genome Res. 2012. PMID: 22673872 Free PMC article.

8

Improved annotation of C. elegans microRNAs by deep sequencing reveals structures associated with processing by Drosha and Dicer.

Warf MB, Johnson WE, Bass BL. Warf MB, et al. RNA. 2011 Apr;17(4):563-77. doi: 10.1261/rna.2432311. Epub 2011 Feb 9. RNA. 2011. PMID: 21307183 Free PMC article.

9

Warf MB, Berglund JA. Warf MB, et al. RNA. 2007 Dec;13(12):2238-51. doi: 10.1261/rna.610607. Epub 2007 Oct 17. RNA. 2007. PMID: 17942744 Free PMC article.

10

The protein factors MBNL1 and U2AF65 bind alternative RNA structures to regulate splicing.

Warf MB, Diegel JV, von Hippel PH, Berglund JA. Warf MB, et al. Proc Natl Acad Sci U S A. 2009 Jun 9;106(23):9203-8. doi: 10.1073/pnas.0900342106. Epub 2009 May 26. Proc Natl Acad Sci U S A. 2009. PMID: 19470458 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15 results

Search Page

Filters